Idiopathic sclerosing mesenteritis

Jump to navigation Jump to search

WikiDoc Resources for Idiopathic sclerosing mesenteritis

Articles

Most recent articles on Idiopathic sclerosing mesenteritis

Most cited articles on Idiopathic sclerosing mesenteritis

Review articles on Idiopathic sclerosing mesenteritis

Articles on Idiopathic sclerosing mesenteritis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Idiopathic sclerosing mesenteritis

Images of Idiopathic sclerosing mesenteritis

Photos of Idiopathic sclerosing mesenteritis

Podcasts & MP3s on Idiopathic sclerosing mesenteritis

Videos on Idiopathic sclerosing mesenteritis

Evidence Based Medicine

Cochrane Collaboration on Idiopathic sclerosing mesenteritis

Bandolier on Idiopathic sclerosing mesenteritis

TRIP on Idiopathic sclerosing mesenteritis

Clinical Trials

Ongoing Trials on Idiopathic sclerosing mesenteritis at Clinical Trials.gov

Trial results on Idiopathic sclerosing mesenteritis

Clinical Trials on Idiopathic sclerosing mesenteritis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Idiopathic sclerosing mesenteritis

NICE Guidance on Idiopathic sclerosing mesenteritis

NHS PRODIGY Guidance

FDA on Idiopathic sclerosing mesenteritis

CDC on Idiopathic sclerosing mesenteritis

Books

Books on Idiopathic sclerosing mesenteritis

News

Idiopathic sclerosing mesenteritis in the news

Be alerted to news on Idiopathic sclerosing mesenteritis

News trends on Idiopathic sclerosing mesenteritis

Commentary

Blogs on Idiopathic sclerosing mesenteritis

Definitions

Definitions of Idiopathic sclerosing mesenteritis

Patient Resources / Community

Patient resources on Idiopathic sclerosing mesenteritis

Discussion groups on Idiopathic sclerosing mesenteritis

Patient Handouts on Idiopathic sclerosing mesenteritis

Directions to Hospitals Treating Idiopathic sclerosing mesenteritis

Risk calculators and risk factors for Idiopathic sclerosing mesenteritis

Healthcare Provider Resources

Symptoms of Idiopathic sclerosing mesenteritis

Causes & Risk Factors for Idiopathic sclerosing mesenteritis

Diagnostic studies for Idiopathic sclerosing mesenteritis

Treatment of Idiopathic sclerosing mesenteritis

Continuing Medical Education (CME)

CME Programs on Idiopathic sclerosing mesenteritis

International

Idiopathic sclerosing mesenteritis en Espanol

Idiopathic sclerosing mesenteritis en Francais

Business

Idiopathic sclerosing mesenteritis in the Marketplace

Patents on Idiopathic sclerosing mesenteritis

Experimental / Informatics

List of terms related to Idiopathic sclerosing mesenteritis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Idiopathic sclerosing mesenteritis (ISM) or mesenteric panniculitus is a rare disease of the small intestine, characterized by chronic inflammation and eventual fibrosis of the mesentery. It has also been called mesenteric lipodystrophy, or retractile mesenteritis.

Historical Perspective

The Mayo Clinic in Rochester, MN, reported a large study of 92 patients, with widely ranging severity of their symptoms. The majority were male, average age 65 years. They commonly had abdominal pain (70%), diarrhea (25%) and weight loss (23%). Depending on the stage of the scarring and fibrosis, several different treatments including surgery, for bowel obstruction, or drugs were used to halt the progression of the disease.

In that case series, 56% of patients received only pharmacological therapy, most often receiving tamoxifen with a reducing dose of reducing prednisone, or also had colchicine, azathioprine or thalidomide.

Their findings suggest that sclerosing mesenteritis can be debilitating although relatively benign. Symptomatic patients benefited from medical therapy, usually tamoxifen and prednisone, but further follow-up information would strengthen these results.

Classification

Pathophysiology

Causes

Differentiating Idiopathic sclerosing mesenteritis from Other Diseases

Epidemiology and Demographics

The epidemiology of Idiopathic sclerosing mesenteritis disease is extremely rare and has only been diagnosed in about an estimated 300 patients worldwide to date (as of 2014), it is probably under diagnosed. It can occur in children.

Risk Factors

Screening

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Sclerosing mesenteritis may present with no or nearly no signs or symptoms, but many people have chronic and severe pain in the abdomen as the most common chief complaint. Other people have chronic problems with bowel movements, resulting in diarrhea, bloating, gas, and cramping which can range from severe to mild.

The disorder is identified by histopathology showing fat necrosis, fibrosis and chronic inflammation of the small intestine. Examination of the mesentery may indicate a solitary mass, but diffuse mesentery thickening is common.

Mechanism

Several causes of sclerosing mesenteritis have been suggested, but the principal pathophysiological mechanism is probably autoimmune. Trauma and prior surgical procedures have also been indicated as possibilities.

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

References

Template:WS Template:WH